These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 8870500)

  • 1. The RNA polymerase II general elongation factors.
    Reines D; Conaway JW; Conaway RC
    Trends Biochem Sci; 1996 Sep; 21(9):351-5. PubMed ID: 8870500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcription factors TFIIF, ELL, and Elongin negatively regulate SII-induced nascent transcript cleavage by non-arrested RNA polymerase II elongation intermediates.
    Elmendorf BJ; Shilatifard A; Yan Q; Conaway JW; Conaway RC
    J Biol Chem; 2001 Jun; 276(25):23109-14. PubMed ID: 11259417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An RNA polymerase II elongation factor encoded by the human ELL gene.
    Shilatifard A; Lane WS; Jackson KW; Conaway RC; Conaway JW
    Science; 1996 Mar; 271(5257):1873-6. PubMed ID: 8596958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure and function of RNA polymerase II elongation factor ELL. Identification of two overlapping ELL functional domains that govern its interaction with polymerase and the ternary elongation complex.
    Shilatifard A; Haque D; Conaway RC; Conaway JW
    J Biol Chem; 1997 Aug; 272(35):22355-63. PubMed ID: 9268387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drosophila ELL is associated with actively elongating RNA polymerase II on transcriptionally active sites in vivo.
    Gerber M; Ma J; Dean K; Eissenberg JC; Shilatifard A
    EMBO J; 2001 Nov; 20(21):6104-14. PubMed ID: 11689450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a 3'-->5' exonuclease activity associated with human RNA polymerase II.
    Wang D; Hawley DK
    Proc Natl Acad Sci U S A; 1993 Feb; 90(3):843-7. PubMed ID: 8381534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcription syndromes and the role of RNA polymerase II general transcription factors in human disease.
    Aso T; Shilatifard A; Conaway JW; Conaway RC
    J Clin Invest; 1996 Apr; 97(7):1561-9. PubMed ID: 8601619
    [No Abstract]   [Full Text] [Related]  

  • 8. The RNA polymerase II elongation complex.
    Aso T; Conaway JW; Conaway RC
    FASEB J; 1995 Nov; 9(14):1419-28. PubMed ID: 7589983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of the MEN/ELL protein, an RNA polymerase II elongation factor, results in transformation of Rat1 cells with dependence on the lysine-rich region.
    Kanda Y; Mitani K; Kurokawa M; Yamagata T; Yazaki Y; Hirai H
    J Biol Chem; 1998 Feb; 273(9):5248-52. PubMed ID: 9478981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification of RNA polymerase II general transcription factors from rat liver.
    Conaway RC; Reines D; Garrett KP; Powell W; Conaway JW
    Methods Enzymol; 1996; 273():194-207. PubMed ID: 8791613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene-specific requirement for P-TEFb activity and RNA polymerase II phosphorylation within the p53 transcriptional program.
    Gomes NP; Bjerke G; Llorente B; Szostek SA; Emerson BM; Espinosa JM
    Genes Dev; 2006 Mar; 20(5):601-12. PubMed ID: 16510875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual roles for transcription factor IIF in promoter escape by RNA polymerase II.
    Yan Q; Moreland RJ; Conaway JW; Conaway RC
    J Biol Chem; 1999 Dec; 274(50):35668-75. PubMed ID: 10585446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and assay of RNA polymerase II elongation factors elongin and ELL.
    Kong SE; Shilatifard A; Conaway RC; Conaway JW
    Methods Enzymol; 2003; 371():276-83. PubMed ID: 14712707
    [No Abstract]   [Full Text] [Related]  

  • 14. Factor-stimulated RNA polymerase II transcribes at physiological elongation rates on naked DNA but very poorly on chromatin templates.
    Izban MG; Luse DS
    J Biol Chem; 1992 Jul; 267(19):13647-55. PubMed ID: 1618865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physical interaction and functional antagonism between the RNA polymerase II elongation factor ELL and p53.
    Shinobu N; Maeda T; Aso T; Ito T; Kondo T; Koike K; Hatakeyama M
    J Biol Chem; 1999 Jun; 274(24):17003-10. PubMed ID: 10358050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the open region of RNA polymerase II transcription complexes in the early phase of elongation.
    Fiedler U; Timmers HT
    Nucleic Acids Res; 2001 Jul; 29(13):2706-14. PubMed ID: 11433015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissection of transcription factor TFIIF functional domains required for initiation and elongation.
    Tan S; Conaway RC; Conaway JW
    Proc Natl Acad Sci U S A; 1995 Jun; 92(13):6042-6. PubMed ID: 7597077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning and characterization of the EAP30 subunit of the ELL complex that confers derepression of transcription by RNA polymerase II.
    Schmidt AE; Miller T; Schmidt SL; Shiekhattar R; Shilatifard A
    J Biol Chem; 1999 Jul; 274(31):21981-5. PubMed ID: 10419521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcription elongation by RNA polymerase II: mechanism of SII activation.
    Reines D; Ghanouni P; Gu W; Mote J; Powell W
    Cell Mol Biol Res; 1993; 39(4):331-8. PubMed ID: 8312968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcription elongation factor SII interacts with a domain of the large subunit of human RNA polymerase II.
    Rappaport J; Cho K; Saltzman A; Prenger J; Golomb M; Weinmann R
    Mol Cell Biol; 1988 Aug; 8(8):3136-42. PubMed ID: 3145407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.